Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal
Abstract Since understanding molecular mechanisms of SARS-CoV-2 infection is extremely important for developing effective therapies against COVID-19, we focused on the internalization mechanism of SARS-CoV-2 via ACE2. Although cigarette smoke is generally believed to be harmful to the pathogenesis o...
Enregistré dans:
Auteurs principaux: | Keiji Tanimoto, Kiichi Hirota, Takahiro Fukazawa, Yoshiyuki Matsuo, Toshihito Nomura, Nazmul Tanuza, Nobuyuki Hirohashi, Hidemasa Bono, Takemasa Sakaguchi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cadfc18f87f14c8381e5f00ac64ea3be |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Angiotensin II promotes the anticoagulant effects of rivaroxaban via angiotensin type 2 receptor signaling in mice
par: Dan Yang, et autres
Publié: (2017) -
Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats.
par: Claudia A McCarthy, et autres
Publié: (2014) -
Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
par: Ivona Yanovna Yarek-Martynova, et autres
Publié: (2010) -
Cyproterone acetate acts as a disruptor of the aryl hydrocarbon receptor
par: Chih-Shou Chen, et autres
Publié: (2021) -
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium
par: Riccardo Terenzi, et autres
Publié: (2017)